BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35562133)

  • 1. Pediatric-type diffuse low grade gliomas: Histomolecular profile and practical approach to their integrated diagnosis according to the WHO CNS5 classification.
    Purkait S; Mahajan S; Sharma MC; Sarkar C; Suri V
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S42-S49. PubMed ID: 35562133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review.
    Thomas DL
    Chin Clin Oncol; 2023 Feb; 12(1):7. PubMed ID: 36922356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review on neuroimaging in pediatric-type diffuse low-grade gliomas.
    Chen J; Qi X; Zhang M; Zhang J; Han T; Wang C; Cai C
    Front Pediatr; 2023; 11():1149646. PubMed ID: 37920791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
    Bale TA; Rosenblum MK
    Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paediatric-type diffuse low-grade gliomas: a clinically and biologically distinct group of tumours with a favourable outcome.
    Fabbri VP; Caporalini C; Asioli S; Buccoliero A
    Pathologica; 2022 Dec; 114(6):410-421. PubMed ID: 36534420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric-type diffuse low-grade glioma with
    Kalelioglu T; Rama B; Cho BB; Lopes BM; Patel SH
    Neuroradiol J; 2023 Apr; 36(2):232-235. PubMed ID: 36074655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 2-Summary of Imaging Findings on Pediatric-Type Diffuse High-Grade Gliomas, Pediatric-Type Diffuse Low-Grade Gliomas, and Circumscribed Astrocytic Gliomas.
    Park YW; Vollmuth P; Foltyn-Dumitru M; Sahm F; Ahn SS; Chang JH; Kim SH
    J Magn Reson Imaging; 2023 Sep; 58(3):690-708. PubMed ID: 37069764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign Glioma.
    Wu PB; Filley AC; Miller ML; Bruce JN
    Adv Exp Med Biol; 2023; 1405():31-71. PubMed ID: 37452934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [World Health Organization Classification of Central Nervous System Tumours, 5
    Ichimura K
    No Shinkei Geka; 2023 Mar; 51(2):349-363. PubMed ID: 37055056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opinion & Special Article: Glioma Classification: How to Interpret Molecular Markers in a Diffuse Glioma Pathology Report.
    van der Meulen M; Ramos RC; Mason WP; Von Deimling A; Maas SLN
    Neurology; 2022 Nov; 99(20):903-908. PubMed ID: 36240081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circumscribed astrocytic gliomas: Contribution of molecular analyses to histopathology diagnosis in the WHO CNS5 classification.
    Köy Y; Tihan T
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S33-S41. PubMed ID: 35562132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major Changes in 2021 World Health Organization Classification of Central Nervous System Tumors.
    Kurokawa R; Kurokawa M; Baba A; Ota Y; Pinarbasi E; Camelo-Piragua S; Capizzano AA; Liao E; Srinivasan A; Moritani T
    Radiographics; 2022; 42(5):1474-1493. PubMed ID: 35802502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
    Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
    Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paediatric type diffuse high grade gliomas in the WHO CNS5 classification: What the pathologist needs to know?
    Rao S; Sahay A; Epari S
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S50-S58. PubMed ID: 35562134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of adult-type diffuse gliomas in the WHO CNS5 classification with special reference to Astrocytoma, IDH-mutant and Oligodendroglioma, IDH-mutant and 1p/19q codeleted.
    Santosh V; Rao S
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S14-S23. PubMed ID: 35562130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.
    Wefers AK; Stichel D; Schrimpf D; Coras R; Pages M; Tauziède-Espariat A; Varlet P; Schwarz D; Söylemezoglu F; Pohl U; Pimentel J; Meyer J; Hewer E; Japp A; Joshi A; Reuss DE; Reinhardt A; Sievers P; Casalini MB; Ebrahimi A; Huang K; Koelsche C; Low HL; Rebelo O; Marnoto D; Becker AJ; Staszewski O; Mittelbronn M; Hasselblatt M; Schittenhelm J; Cheesman E; de Oliveira RS; Queiroz RGP; Valera ET; Hans VH; Korshunov A; Olar A; Ligon KL; Pfister SM; Jaunmuktane Z; Brandner S; Tatevossian RG; Ellison DW; Jacques TS; Honavar M; Aronica E; Thom M; Sahm F; von Deimling A; Jones DTW; Blumcke I; Capper D
    Acta Neuropathol; 2020 Jan; 139(1):193-209. PubMed ID: 31563982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.
    Ramkissoon LA; Horowitz PM; Craig JM; Ramkissoon SH; Rich BE; Schumacher SE; McKenna A; Lawrence MS; Bergthold G; Brastianos PK; Tabak B; Ducar MD; Van Hummelen P; MacConaill LE; Pouissant-Young T; Cho YJ; Taha H; Mahmoud M; Bowers DC; Margraf L; Tabori U; Hawkins C; Packer RJ; Hill DA; Pomeroy SL; Eberhart CG; Dunn IF; Goumnerova L; Getz G; Chan JA; Santagata S; Hahn WC; Stiles CD; Ligon AH; Kieran MW; Beroukhim R; Ligon KL
    Proc Natl Acad Sci U S A; 2013 May; 110(20):8188-93. PubMed ID: 23633565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors.
    Chen W; Jin S; Liu Q; Wang H; Xia Y; Guo X; Guo S; Wang Y; Shi Y; Liu D; Li Y; Wang Y; Xing H; Li J; Wu J; Liang T; Qu T; Li H; Yang T; Zhang K; Wang Y; Ma W
    Front Neurosci; 2023; 17():1144559. PubMed ID: 37214395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Low grade glioma with MYBL1 alteration: Case report of an uncommon pediatric neoplasm].
    Appay R; Tauziède-Espariat A; Silva K; Fritih R; Scavarda D; Delteil C; Varlet P; Figarella-Branger D
    Ann Pathol; 2021 Feb; 41(1):129-133. PubMed ID: 32732147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult-type and Pediatric-type Diffuse Gliomas : What the Neuroradiologist Should Know.
    Nafe R; Porto L; Samp PF; You SJ; Hattingen E
    Clin Neuroradiol; 2023 Sep; 33(3):611-624. PubMed ID: 36941392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.